Prognostic factors for salvage radiotherapy with an analysis of post-prostatectomy PSA kinetics (original) (raw)
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results
Thomas Wiegel
World Journal of Urology, 2013
View PDFchevron_right
Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy
Takeshi Kodaira
Journal of Cancer Research and Clinical Oncology, 2009
View PDFchevron_right
Achieving an Undetectable PSA After Radiotherapy for Biochemical Progression After Radical Prostatectomy Is an Independent Predictor of Biochemical Outcome—Results of a Retrospective Study
Thomas Wiegel
International Journal of Radiation Oncology*Biology*Physics, 2009
View PDFchevron_right
Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancer
Thomas Wiegel
European Journal of Cancer, 2009
View PDFchevron_right
Dose Escalation for Patients with Decreasing PSA during Radiotherapy for Elevated PSA after Radical Prostatectomy Improves Biochemical Progression-Free Survival
Thomas Wiegel
Strahlentherapie und Onkologie, 2011
View PDFchevron_right
(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy
Cyril Danjoux, Gerard Morton
International Journal of Radiation Oncology*Biology*Physics, 2002
View PDFchevron_right
PSA Progression Following Radical Prostatectomy and Radiation Therapy: New Standards in the New Millenium
Alexandre Zlotta
European Urology, 2003
View PDFchevron_right
Prognostic factors of persistently detectable PSA after radical prostatectomy
Bruno Spina
International Journal of Urology, 2009
View PDFchevron_right
Salvage Radiotherapy for Patients with PSA Relapse Following Radical Prostatectomy: Issues and Challenges
F. Desgrandchamps
2010
View PDFchevron_right
A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy
Karin Haustermans
Radiotherapy and Oncology, 2010
View PDFchevron_right
Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
Pierre Mongiat-artus
BMC Cancer, 2008
View PDFchevron_right
Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients
Marc Zerbib
Urology, 2003
View PDFchevron_right
Changes in prostate-specific antigen midway through salvage radiotherapy may be associated with long-term outcomes
Harmar Brereton
Journal of Radiation Oncology, 2019
View PDFchevron_right
Serum Prostate-Specific Antigen Profile Following Radiotherapy for Prostate Cancer: Implications for Patterns of Failure and Definition of Cure
Juanita Crook
Urology, 1998
View PDFchevron_right
Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer - focus on overall survival
Michael Pinkawa
Radiation oncology (London, England), 2017
View PDFchevron_right
Prostate specific antigen levels during radical radiation therapy and the prediction of outcome in localized carcinoma of the prostate
Tony Panzarella
Clinical Oncology, 1997
View PDFchevron_right
Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy
Stephen Freedland
Urology, 2003
View PDFchevron_right
Treatment Outcomes from 68Ga-PSMA PET/CT–Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
Raj Jagavkar
The Journal of Nuclear Medicine, 2017
View PDFchevron_right
Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study
Manabu Aoki, Takuyo Kozuka
Journal of radiation research, 2015
View PDFchevron_right
Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
Roberto Miano
British journal of cancer, 2000
View PDFchevron_right
Outcome of Prostate Cancer Patients with Initial PSA ≥ 20 ng/ml Undergoing Radical Prostatectomy
jan lehmann
European Urology, 2007
View PDFchevron_right
Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy
Alexandre Jacinto, Marcus Castilho, Paulo E Novaes, Lívia Fagundes, Joao Salvajoli
Radiation oncology (London, England), 2007
View PDFchevron_right
Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: Prognostic value of a time-and-PSA threshold model
chandana reddy
Cancer, 2004
View PDFchevron_right
Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy
Deep Patel
2005
View PDFchevron_right
Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomy
Emilie Hénin
The Prostate, 2009
View PDFchevron_right